- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba unveils JustVision scanners
Japanese ultrasound developer Toshiba unveiled a new line of compact scanners at last month's International Congress of Radiology meeting in New Delhi, India. The line consists of JustVision 200, a hand-carried unit that weighs just 16 kg, and JustVision
Japanese ultrasound developer Toshiba unveiled a new line of compact scanners at last month's International Congress of Radiology meeting in New Delhi, India. The line consists of JustVision 200, a hand-carried unit that weighs just 16 kg, and JustVision 400, a cart-mounted system with a larger monitor.
Both JustVision systems are convex and linear scanners that include transducers that support abdominal, ob/gyn, intraoperative, superficial, and cardiovascular applications. In addition, JustVision transducers can be switched between three different frequencies depending on the depth of the region of interest. The feature enables sonographers to use one probe for exams that might otherwise require three scanheads.
Toshiba plans to roll out the JustVision line internationally this month. The company will begin marketing the systems in the U.S. in early 1999, according to a spokesperson with the vendor's U.S. subsidiary, Toshiba America Medical Systems in Tustin, CA.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
